The technique, known as optogenetics, was successfully trialled in France with input from the Institute of Molecular and Clinical Ophthalmology Basel (IOB), which is affiliated with the University of Basel.
Cells in the man’s retina were programmed to produce a protein called ChrimsonR, which is sensitive to light. The protein is naturally produced by algae to help them detect light.
The patient, who had been completely blind for two decades due to a condition known as retinitis pigmentosa, was first able to detect painted stripes on a pedestrian crossing and then to count objects on a table.
The results of the trial were first published in the journal Nature MedicineExternal link. The trial was a collaboration between the IOB, the University of Pittsburgh, the Institute of Vision in Paris, Streetlab and GenSight Biologics.
Around 115 researchers work at the IOB, which is financed by pharmaceutical company Novartis, the University of Basel, the University Hospital Basel and the canton of Basel.
While optogenetics has now been shown as a viable treatment for blindness, researchers cautioned that as the technique is new its full potential has yet to be determined.
First large-scale alpine solar plant approved in Switzerland
This content was published on
The approval was met with satisfaction by the project's organisers, but it also brings with it a certain amount of pressure.
Medieval squirrels may have ‘helped spread leprosy’
This content was published on
An examination of squirrel remains in the United Kingdom has opened up interesting questions and possibilities in terms of the history of the disease.
Swiss money laundering office registers record number of reports
This content was published on
The Money Laundering Reporting Office Switzerland (MROS) registered a record number of reports of suspicious activity last year.
Two teens accused of planning terror attack released from custody
This content was published on
The Schaffhausen judiciary has released the two teenagers from custody who allegedly planned bomb attacks in Switzerland.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Blind patient gets “bionic eye” implant
This content was published on
The device uses a camera mounted on a pair of glasses to feed visual information to electrodes in the eye, allowing the patient to see light, shapes and movement. “It’s close to science fiction,” Avinoam Safran, head of the ophthalmology department at Geneva’s University Hospital, told swissinfo. “Ten years ago we couldn’t have imagined attaining…
This content was published on
Using targeted radiotherapy they say they are able to prevent damage to healthy tissue and even loss of the eye. But the scientists at Lausanne University Hospital and the Jules Gonin clinic are cautious about the therapy’s success rate. So far just three babies have undergone the treatment. At least two years have to pass…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.